Investor Relations
Investor Relations Contact:
LHA
Anne Marie Fields
212-838-3777
afields@lhai.com
or
Bruce Voss
310-691-7100
bvoss@lhai.com

Media Contact
Rooney & Associates
Terry Rooney
212-223-0689
trooney@rooneyco.com
or
Marion Janic
212-223-4017
mjanic@rooneyco.com

OPKO Health Announces KDIGO Clinical Practice Guideline Update on CKD-MBD more »

OPKO Provides Update to Topline Data of Phase 3 Clinical Study of hGH-CTP in Growth Hormone Deficient Adults more »

OPKO'S GeneDx Extends Relationship with University of California Health for Genetic and Molecular Testing more »

OPKO Health Provides Commercial Update for RAYALDEE more »

Code of Business Conduct and Ethics

Code of Business Conduct and Ethics Introduction

The Board has adopted a Code of Business Conduct and Ethics that applies to all of our directors, officers (including our Chief Executive Officer, our Chief Financial Officer, and our principal accounting officer), and employees.

Notice of Amendment:
On June 14, 2012, the Company's Board of Directors amended its Code of Business Conduct and Ethics to, among other things, further define various transactions which would constitute a conflict of interest, include provisions prohibiting usurpation of corporate opportunities, impose requirements of fair dealing and confidentiality, and clarify various reporting procedures and obligations for responding to government investigations and media or public inquiries.


PDF Click here for OPKO's Code of Business Conduct and Ethics   1.6 MB

Email  Sign up for email alerts